Biodesix Inc. (BDSX) Misses Q4 EPS by 7c

Biodesix Inc. (NASDAQ: BDSX) reported Q4 EPS of ($0.35), $0.07 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $9.61 million versus the consensus estimate of $10.77 million.

For earnings history and earnings-related data on Biodesix Inc. (BDSX) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• SPAR Group (SGRP) Reports Q2 EPS of $0.04
• Pulmatrix (PULM) Reports Q2 Loss of $0.29